Research articlePublished 2018
Evaluation of Thyroid Functions in Patients with Multiple Sclerosis Before and after Treatment with Interferon Beta
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
Background: Multiple sclerosis (MS) is a multi-component disease characterized by inflammation, neurodegeneration and failure of central nervous system (CNS) repair mechanisms. Autoimmune thyroid disease is a frequently studied disorder in MS, most studies have focused primarily on the increased prevalence of thyroid dysfunction and anti-thyroid antibodies (ATAs) in MS patients compared with a control population. Objectives: To investigate the effect of treatment with interferon beta on thyroid functions and autoimmune thyroid markers in patients with multiple sclerosis. Subjects and Methods: This prospective study was conducted on 100 subjects recruited from the inpatient and outpatient clinic of Internal Medicine department and Neurology Unit of Ain Shams University Hospitals. They were divided into group 1, which included 50 patients newly diagnosed with multiple sclerosis according to Macdonald’s criteria 2010 and group 2, which included 50, age and sex matched healthy volunteers. All participants were exposed before and 6 months after treatment with interferon beta to Expanded disability status scale (EDSS), which is a method of quantifying disability in multiple sclerosis, Free T4, Free T3 and TSH, Anti thyroid peroxidase (anti- TPO) and anti-thyroglobulin (anti TG) antibodies, MRI brain and neck ultrasonography. Results: Anti thyroid peroxidase antibody levels were significantly higher in the drug naïve patients group after treatment with interferon beta (29.660 ± 28.755 IU/ml) in comparison to their baseline values (17.580 ± 4.982 IU/ml) (p-value=0.004). Anti-thyroglobulin antibody levels were significantly higher too after treatment with interferon beta (33.920 ± 32.553 IU/ml) in comparison to baseline values (24.560 ± 20.101 IU/ml) (p- value=0.01). Conclusion: IFN-β therapy has a strong impact on the auto-immune thyroid markers status and levels in drug naïve MS patients causing increase in both anti TPO and anti TG positivity statues and numerical values.
Subjects
Diabetes & EndocrinologyAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalJournal of Thyroid Disorders & Therapy
- SubjectDiabetes & Endocrinology
- BylineArticles whose byline prints “Magda Shokry Mohammed”
- BylineArticles whose byline prints “Nihad Shoukry Shoeib”
- BylineArticles whose byline prints “Inas Mohammed Sabry”
- BylineArticles whose byline prints “Dina Mohammed Abd El Gawad”
- BylineArticles whose byline prints “Ahmed Mohamed Bahaaeldin”
- BylineArticles whose byline prints “Nahla Nader Adly”
